環后癌 的英文怎麼說

Studies revealed that p - catenin dissociated from ccc and translocated into free catenin pool in cytosol after it has been phosphorylated at tyrosine or serine residues, and in this situation, the ccc has been disrupted and cell adhesion function disturbed. a large amount of the free p - catenins in the cytosol can be degraded by the tumor suppressor apc, and the remains translocate into nucleus and bind to transcriptional factor tcf / lef in the nucleus and then promote cell proliferation related gene or anti - apoptosis gene transcription

當-連環蛋白酪氨酸或絲氨酸殘基磷酸化后，就與ajs發生解離而游離到細胞漿中，此時細胞的粘附功能也發生障礙，游離到胞漿中的-連環蛋白，一部分被抑癌因子apc降解，一部分則轉移到細胞核內，與核內的轉錄因子tcf lef結合，啟動與細胞增殖有關的基因轉錄。

In this report, we mainly covered the following aspects of " tissue organ regeneration and replication in situ " : 1 ) procedures of tissue organd regeneration and replication and replication in clnical practice ; 2 ) the discover and existence of potentiald regenerative cell ( prc ) ; 3 ) the proliferation, differentiation and regeneration law of potential law of potential regenerative cells ; 4 ) study procedure on tissue organ regeneration and replication from prcs in vitro based on the model of full skin organ regeneration in situ after extensive in vitro, set up the method and technology of searching life regenerative substance required in tissue organ regeneration and replication in situ. in this study, first, the whole human body is divided into 206 function units, which are the " tissue organ " in regeneration study. then the histology foundation of tissue organ regeneration and replication in situ is set up. in ordre to prove the existence of the potential regenerative cells and their potential baility and function, we established clinical tracking rechnique of skin organ regeneration in situ ; meanwhile, several tissue organ regeneration and replication in vitro models which represent different kinds of runctions were sucessfully set up, with all these techniques and models, we confirmed : 1 ) the existence, function and ability of pptemtoa regenerative cells ; 2 ) the importance of life regenerative substance ; 3 ) the feasibility of tissue organ regeneration and replication in situ ; 4 ) the big value of tissue organ regeneration and replication in situ in life science and medicine progerss. we also showed the possible foreground of capture cancer with this method and technologh. in this report, nearly 200 photographs of several tissue organ regeneration and replication in situ or in vitro demonstrated the whole process of tissue organ and big organ entities regeneration and replication from cells. the results of tissue organ regeneration and replication in situ mainly include : 1 ) whole skin organ regeneration and replication in situ ; 2 ) gastrointestinal mucosa tissue organ regeneration in vitro ; 3 ) hair follicle tissue organ regeneration in situ or in vitro ; 4 ) never tissue organ regeneration in situ ; 5 ) pancreas tissue organ regeneration and replication in vitro ; 5 ) marrow tissue regeneration in vitro ; 6 ) renal glomerulus and tubule tissue organ tugeneraation in vitro ; 7 ) heart muscle regeneration in vitro, etcl. in order to let more and more people know and understand this technology of tissue organd regeneration and replication in situ, herein, for the first time, we publicize the key points of actualizing this technology. also, we publicized the technology procedures and the frame constitute of life substances. we bilieve this is a big contribution to human science

本研究報告，重點報道了組織器官的原位再生復制的臨床程序，報道了組織潛能再生細胞的發現和存在，以及該細胞的增殖分化和形成組織器官的變化規律.以燒傷后皮膚組織器官的原位再生復制為模型，研究出了體外組織潛能再生細胞復制組織器官的培養方法;以體外組織器官的復制為模型，建立了尋找原位組織器官再生復制所需生命物質的方法和技術.本研究，首先按人體的器官功能，分解為206個功能單位，確立了所復制的人體器官中的組織功能單位為組織器官，從而建立了原位組織器官再生復制的組織學基礎.為了驗證組織潛能再生細胞的再生潛能，建立了皮膚器官原位再生的實體臨床跟蹤技術，同時又建立了能代表有關器官功能類別的代表組織器官的原位和體外復制模型，以多組織器官的成功復制確定潛能再生細胞的作用，確定生命研究再生物質的重要性，確定組織器官原位再生復制的可行性，確定了組織器官原位再生復制的生命科學研究和醫學進步的重大應用價值，同時展示了用此方法和技術攻克癌癥的前景.本研究報告，以近二百幅多個組織器官原位和體外再生復制的實體圖片，展示了潛能再生細胞復制的組織器官和大器官司實體;展示了細胞再生復制器官的全過程.真實的報告了組織器官原位再生復制的成果.所公布的主要成果為:皮膚器官的原位再生復制;胃腸黏膜組織器官的原位和體外再生復制;毛囊組織器官的原位和體外再生復制;神經組織器官的原位復制;胰腺組織器官的體外復制;骨髓組織的體外復制;腎小球小管組織器官的體外復制;心肌的體外復制等.為了讓更多的人學會和掌握組織器官原位再生復制技術，本報告首次公布實施技術的重要環節和技術流程;首次公布了生命再生物質的框架和組成.作者自費研究成果對人類生命科學的一大貢獻

1999 lance continues his comeback from cancer with his first victory at the tour de france. he does it on a 5500 oclv carbon stock bike

1999年蘭斯以他在環法自行車賽上第一個冠軍繼續他戰勝癌癥后的上升期。這個冠軍是他用一輛使用了5500oclv碳纖維的自行車取得的。

Entries were judged by a panel of leading science communicators and scientists who selected 10 runners - up and 6 overall winners spread across six different media categories. the winning entries include a newspaper investigation report on suspected academic fraud, a periodical article on mouse experiments in cancer research, an ecological report on poyang lake, a radio piece about a marine scientists academic pursuits, a tv item on chinas first digital human body and an english language article about polar science of a chinese research vessel called the dragon snow.

優勝作品包括一篇刊載于報紙上關于學術領域的質疑式調查性報道，一篇刊載于期刊上介紹由一隻具有抗癌能力的實驗小鼠帶來的抗癌新發現的報道，一篇關于鄱陽湖生態環境方面的報道，一期講述一位海洋生物學家學術追求的廣播節目，一臺介紹中國首例數字虛擬人形成過程的電視節目以及講述雪號歸來后中國科學界推出的累累碩果的英文報道。

Clsm, afm and tem testified the deposition of these drugs and the experiments carried out in ( 1 ) different initial incubation concentration, ( 2 ) different temperature, ( 3 ) different nacl concentration and ( 4 ) different ph revealed that the drugs have a relative high deposition efficiency in the high initial incubation concentration, high temperature, high nacl concentration and high ph environment, and relatively stable release properties in the low initial incubation concentration, low temperature, high nacl concentration and low ph environment

在（ 1 ）不同初始濃度、 （ 2 ）不同溫度、 （ 3 ）不同鹽濃度和（ 4 ）不同ph值下對模型藥物rdb和抗癌藥物dnr沉積和釋放的研究發現高初始濃度、高溫、高鹽和高ph值環境下有利於藥物的沉積；而低初始載藥量、低溫、高鹽和低ph值環境下，沉積后的藥物則具有相對平緩的釋放性能。

" the excess of cancer after a breast cancer diagnosis is likely to be explained by treatment for breast cancer and by shared genetic or environmental risk factors, although the general excess of cancer suggests that there may be additional explanations such as increased surveillance and general cancer susceptibility, " the authors conclude

研究人員在報告中總結說： 「對於一個人在被確診患有乳腺癌后仍然出現其它種類癌癥的情況，或許可以將其歸咎于為治愈乳腺癌而不得不去接受的各種治療，以及這些人所共同面對的基因或環境方面的危險因素。